Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G0HP
|
||||
Former ID |
DNC007543
|
||||
Drug Name |
SALVINICIN B
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528906] | ||
Structure |
Download2D MOL |
||||
Formula |
C25H36O12
|
||||
Canonical SMILES |
CC(=O)OC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4(C(C(OC4OC)OC<br />)O)O)C)C(=O)OC
|
||||
InChI |
1S/C25H36O12/c1-11(26)35-14-9-13(19(29)32-4)23(2)8-7-12-20(30)36-15(10-24(12,3)17(23)16(14)27)25(31)18(28)21(33-5)37-22(25)34-6/h12-15,17-18,21-22,28,31H,7-10H2,1-6H3/t12-,13-,14-,15?,17-,18+,21+,22-,23-,24-,25+/m0/s1
|
||||
InChIKey |
QEBAQEQKIKWXTO-CKKULBRGSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [528906] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.